Eastern Hepatobiliary Surgery Hospital
🇨🇳China
Standard Treatments of Very-early Stage Hepatocellular Carcinoma
Not Applicable
Completed
- Conditions
- Very-early StageHepatocellular Carcinoma
- Interventions
- Procedure: MWVProcedure: RFAProcedure: PEI
- First Posted Date
- 2016-04-05
- Last Posted Date
- 2016-04-05
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT02728193
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology
Completed
- Conditions
- Cancer Stem CellsPostoperative Recurrence and MetastasisHepatocellular Carcinoma
- First Posted Date
- 2016-04-04
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT02727673
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Not Applicable
Completed
- Conditions
- Hepatocellular CarcinomaLaser AblationPortal Vein Tumor Thrombus
- Interventions
- Procedure: 3D-CRTProcedure: LA
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT02724475
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Postoperative Adjuvant TACE Treatment in CK18 Positive Patients
Completed
- Conditions
- Postoperative Adjuvant TACEHepatocellular Carcinoma.
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT02724345
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT02724332
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma
Not Applicable
Completed
- Conditions
- Hepatocellular CarcinomaRadioembolization
- Interventions
- Procedure: TACEProcedure: radioembolization with Y-90
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT02724436
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Targeted Internal Radiation Therapy in Advanced HCC Patients.
Not Applicable
Completed
- Conditions
- Advanced Hepatocellular CarcinomaInternal Radiation
- Interventions
- Biological: 131I-chTNT-1/B
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT02724267
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1
Not Applicable
Completed
- Conditions
- Notch1Rg3Hepatocellular CarcinomaTACE
- Interventions
- Drug: Rg3Procedure: protective therapyOther: TACE + Rg3Procedure: TACE
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT02724358
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection
Not Applicable
- Conditions
- Intrahepatic Cholangiocarcinoma
- Interventions
- Procedure: TACE+TegafurProcedure: TACE
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT02588755
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH
Phase 1
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Procedure: TACE
- First Posted Date
- 2015-10-27
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT02587884
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath